Search results
Results From The WOW.Com Content Network
Hemgenix is an adeno-associated virus vector-based gene therapy indicated for treatment of adults with Hemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes.
Effective Date: 06/06/2024Medical benefit drug policies are a source for Wellmark Advantage Health Plan medic. policy information only. These documents are not to be used to determine. enefits or reimbursement. Please reference the appropriate certificate or contra. for benefit information. This policy may be updated and t.